Insights

Early-stage Biotech Evercrisp Biosciences is a small to mid-sized biotech startup (11-50 employees) with a clear focus on innovative genetic therapy delivery. This presents an opportunity to engage in strategic partnerships, pilot programs, or early access collaborations with pharma, contract research, or academic grant-funded projects seeking novel delivery platforms.

Self-Delivering Miniproteins The company’s proprietary self-delivering miniproteins that bypass traditional delivery vehicles (LNPs, viral vectors) address a key industry pain point — reducing immune responses and delivery barriers. This creates sales potential for platforms seeking safer, more scalable gene therapy modalities and for CROs needing differentiated delivery solutions for their programs.

Targeted Tissue Reach With capability to access brain, kidney, muscle, and other tissues previously unreachable by genetic medicines, Evercrisp offers potential collaboration avenues for programs targeting CNS disorders, nephrology, muscular diseases, and rare conditions. This can be leveraged in outreach to biotech groups pursuing tissue-specific gene therapies.

Growth Readiness Revenue is in the low to mid single digits (1–10M) with a lean team, indicating a scalable partner for co-development, licensing, or material supply agreements. BD efforts can emphasize near-term collaboration milestones, pilot studies, and joint development opportunities that fit a growing company’s runway.

Technology & Ecosystem Fit Adoption of mainstream tech stack and modern web presence suggests readiness for formal partnerships, technology licensing discussions, and joint marketing or visibility programs. Initiatives could include co-branding with research institutions, participation in biotech accelerators, or supplier/vendor partnerships to scale operations.

Similar companies to Evercrisp Biosciences

Evercrisp Biosciences Tech Stack

Evercrisp Biosciences uses 8 technology products and services including html5media, RSS, WordPress, and more. Explore Evercrisp Biosciences's tech stack below.

  • html5media
    Audio, Video, Graphics
  • RSS
    Content Management System
  • Content Management System
  • jQuery Migrate
    Javascript Libraries
  • Lenis
    Javascript Libraries
  • Team Collaboration
  • Apache
    Web Servers

Evercrisp Biosciences's Email Address Formats

Evercrisp Biosciences uses at least 3 email formats:
Evercrisp Biosciences Email FormatsExamplePercentage
FLast@evercrispbiosciences.comJDoe@evercrispbiosciences.com
89%
First@evercrispbiosciences.comJohn@evercrispbiosciences.com
11%
FLast@evercrispbio.comJDoe@evercrispbio.com
100%

Frequently Asked Questions

What is Evercrisp Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Evercrisp Biosciences's official website is evercrispbio.com and has social profiles on LinkedIn.

How much revenue does Evercrisp Biosciences generate?

Minus sign iconPlus sign icon
As of October 2026, Evercrisp Biosciences's annual revenue is estimated to be $1M - $10M.

What is Evercrisp Biosciences's SIC code and NAICS code?

Minus sign iconPlus sign icon
Evercrisp Biosciences's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Evercrisp Biosciences have currently?

Minus sign iconPlus sign icon
As of October 2026, Evercrisp Biosciences has approximately 22 employees across 2 continents, including North America and South America. Key team members include Senior Scientist: P. Z. and Associate Scientist: C. A. Explore Evercrisp Biosciences's employee directory with LeadIQ.

What industry does Evercrisp Biosciences belong to?

Minus sign iconPlus sign icon
Evercrisp Biosciences operates in the Biotechnology Research industry.

What technology does Evercrisp Biosciences use?

Minus sign iconPlus sign icon
Evercrisp Biosciences's tech stack includes html5media, RSS, WordPress, Microsoft 365, jQuery Migrate, Lenis, Box and Apache.

What is Evercrisp Biosciences's email format?

Minus sign iconPlus sign icon
Evercrisp Biosciences's email format typically follows the pattern of FLast@evercrispbiosciences.com. Find more Evercrisp Biosciences email formats with LeadIQ.

When was Evercrisp Biosciences founded?

Minus sign iconPlus sign icon
Evercrisp Biosciences was founded in 2021.
Evercrisp Biosciences logo

Evercrisp Biosciences

Biotechnology ResearchCalifornia, United States11-50 Employees

Evercrisp Biosciences is a biotechnology research company focused on developing delivery methods for genetic therapies. Its work aims to enable precise, safe, and scalable delivery into tissues such as the brain, kidney, and muscle, using proprietary approaches to create miniproteins that can access areas previously unreachable by genetic medicines. These self-delivering miniproteins are designed to function without auxiliary delivery vehicles that can provoke immune responses, addressing a key challenge in delivering genetic therapies. The company is based in Berkeley, California, and operates within the biotechnology research sector, seeking to serve researchers and developers pursuing advanced genetic medicine delivery solutions. With a relatively small and specialized team, Evercrisp emphasizes its foundational science drawn from experienced scientific founders to support its development efforts. A recent development highlight indicates ongoing progress in advancing its delivery capabilities for targeted tissues.” } } { } { } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } } }

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
11-50

Section iconFunding & Financials

  • $1M - $10M

    Evercrisp Biosciences's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.